Amarantus Bioscience Holdings Inc (CE) (AMBS) Actualités

Sec Staff Action/letter (sec Staff)

Amended Statement of Beneficial Ownership (sc 13d/a)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   SCHEDULE 13D   Under the Securities Exchange...

Amended Statement of Beneficial Ownership (sc 13d/a)

  UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   SCHEDULE 13D   Under the Securities...

Statement of Beneficial Ownership (sc 13d)

  UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   SCHEDULE 13D  ...

Statement of Beneficial Ownership (sc 13d)

  UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   SCHEDULE 13D   Under...

Statement of Beneficial Ownership (sc 13d)

  UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   SCHEDULE 13D  ...

Todos Medical Expands Extraction Reagent and ANDiS 350 Extraction Automation Capacity to Support COVID-19 Testing in the USA

Full US use of ANDiS 350 extraction systems would increase US daily testing capacity by 25% 3D Med extraction capacity increased by 1,000,000...

Amarantus Acquires Majority Interest in CBD Wellness Company Hempori

Amarantus Acquires Majority Interest in CBD Wellness Company Hempori    Strong customer retention at both stores in Dallas, TX...

Withdrawal of Offering Statement Under Regulation a (1-a-w)

  AMARANTUS BIOSCIENCE HOLDINGS, INC.       January 9...

Amended Registration a Offering Under the Securities Act of 1933 (1-a/a)

Form 1-A Issuer Information FORM 1-A UNITED STATE SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549FORM 1-A REGULATION A OFFERING...

Registration a Offering Under the Securities Act of 1933 (1-a)

Form 1-A Issuer Information FORM 1-A UNITED STATE SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549FORM 1-A REGULATION A OFFERING...

Registration a Offering Under the Securities Act of 1933 (1-a)

Form 1-A Issuer Information FORM 1-A UNITED STATE SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549FORM 1-A REGULATION A OFFERING...

Amarantus Provides 2019 Roadmap

  Amarantus Provides 2019 Roadmap   New York, NY -- January 7, 2019 -- InvestorsHub NewsWire -- Amarantus Bioscience...

Coeptis Pharma Enters into Agreement to Acquire Elto Pharma

    Coeptis Pharma Enters into Agreement to Acquire Elto Pharma   New York, NY and Wexford, PA -- November 28...

Amarantus Provides Corporate Update

  Amarantus Provides Corporate Update   New York, NY -- July 20, 2018 -- InvestorsHub NewsWire -- Amarantus Bioscience...